AhR activation in the liver induces the endocrine hormone FGF21, which protects against obesity and insulin resistance, uncoupling hepatic steatosis from insulin resistance [169]. The gene discussed is AHR; the disease is obesity due to melanocortin 4 receptor deficiency.